In a 62-day study of 25 people with obesity, an intermittent energy restriction (IER) diet led to average weight loss of 7.6 kg (16.8 lb) and rapid, linked changes in gut microbiome composition and brain activity. fMRI scans showed altered activity in appetite- and addiction-related regions, including the left inferior frontal orbital gyrus, while stool and blood tests identified microbial shifts correlated with those brain changes. Specific bacteria, such as Coprococcus comes and Eubacterium hallii, were associated with reduced activity in that frontal region. Researchers say larger studies are needed to confirm mechanisms and evaluate long-term implications for obesity treatment.
Intermittent Energy Restriction Rapidly Alters Gut Microbiome and Brain Activity During Weight Loss

Similar Articles

Gut Microbe and Its Metabolite May Trigger an Ozempic‑Like GLP‑1 Response — A Potential Natural Way to Curb Sugar Cravings
Researchers at Jiangnan University report that the gut bacterium Bacteroides vulgatus and one of its metabolites increased GL...

30% Calorie Cut May Protect the Aging Brain, Monkey Study Suggests
A Boston University study of 24 rhesus monkeys fed either standard or calorie-restricted diets for more than 20 years found t...

Tirzepatide Quieted 'Food Noise' in a Brain-Recorded Case — Effect Wore Off After Several Months
This small brain-recording case followed a 60-year-old woman with obesity and loss-of-control eating who was taking tirzepati...

Aging Scrambles Brain Protein Tags — Short Calorie Restriction Reverses Some Changes
The Leibniz Institute on Aging used mass spectrometry to compare brain proteins in young and old mice and found age-related c...

Daily Orange Juice Alters Nearly 3,800 Genes — Potential Boost for Heart and Metabolic Health
A 60-day trial gave 20 healthy adults 500 mL of pasteurized 100% orange juice daily and used transcriptomics to compare blood...

Daily Oral GLP‑1 Pill Cuts About 10% of Body Weight in 18 Months, Study Finds
Trial results: Orforglipron, an investigational oral GLP‑1, produced about 10% average body‑weight loss after 72 weeks in adu...

This Week in Science: Oral Ozempic Alternative, Insulin Skin Cream, Mars Meteorite and More
This week’s highlights: orforglipron, an oral small-molecule candidate, produced dose-dependent weight loss comparable to inj...

Low-dose Ozempic-like Drug Produces ‘Younger’ Molecular Profile in Mice — Human Effects Unknown
Researchers treated middle-aged mice with low-dose exenatide, a GLP-1 receptor agonist similar in action to semaglutide, for ...

Metformin’s Brain Link: Study Shows Rap1 in the Ventromedial Hypothalamus Is Required for Its Glucose-Lowering Effect in Mice
The study in Science Advances shows that metformin reaches the ventromedial hypothalamus and suppresses a brain protein calle...

WHO: Weight‑loss Injections Can Help — But They Won’t Solve the Global Obesity Crisis
The WHO says injectable GLP‑1 drugs (liraglutide, semaglutide, tirzepatide) can support weight loss in adults but are not a s...

MEOW-1 Trial Tests Microchip-Sized GLP-1 Implant to Reduce Obesity in Cats
Okava Pharmaceuticals has launched MEOW-1, a trial of a microchip-sized implant that releases a GLP-1 drug over three months ...

15 Surprising Facts About the Human Brain That Will Blow Your Mind
Summary: The human brain is a high-energy, highly adaptable organ that uses about 20% of the body's energy, continually rewir...

How Breathing Times Memory: EEG Study Links Inhales and Exhales to Recall
EEG recordings show that memory retrieval is temporally linked to the breathing cycle: a reduction in alpha/beta activity sig...

After 60 Years, Metformin Found to Act Directly on the Brain — Mouse Study Reveals New Pathway
Researchers report that metformin reaches the ventromedial hypothalamus (VMH) in mice and suppresses the Rap1 protein, improv...

Mouse Study Suggests Soybean Oil Metabolites May Promote Weight Gain
A Journal of Lipid Research study in mice found that metabolites (oxylipins) produced when the body processes linoleic acid i...
